The management of hypertension in the African American patient.
A panel was convened to discuss the topic of the management of hypertension in the African American patient. Jackson T. Wright, MD, PhD, Professor of Medicine, Case Western Reserve University, Cleveland, OH, moderated the panel. Kenneth A. Jamerson, MD, Professor of Medicine, University of Michigan, Ann Arbor, MI, and Keith C. Ferdinand, MD, Association of Black Cardiologists, Inc, and Emory University, Atlanta, GA, participated in the discussion. This expert panel discussion was supported by Novartis and each author received an honorarium from Novartis for time and effort spent participating in the discussion and reviewing the transcript for important intellectual content prior to publication. The authors maintained full control of the discussion and the resulting content of this article; Novartis had no input in the choice of topic, speakers, or content.
Wright
Jackson T
JT
Medicine, Case Western Reserve University, Cleveland, OH, USA.
Jamerson
Kenneth A
KA
Ferdinand
Keith C
KC
D001741:Black or African American / Q000208:ethnology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004032:Diet; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000208:ethnology* / Q000628:therapy*; D008019:Life Style; D008403:Mass Screening; D009749:Nutrition Surveys; D015995:Prevalence; D014481:United States / Q000208:ethnology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers